Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy
NEW ENGLAND JOURNAL OF MEDICINE(2023)
Abstract
Dystrophin Immunity after Gene Therapy for DMD Five boys with Duchenne's muscular dystrophy received three different AAV products. Serious adverse reactions consistent with transgene expression occurred, and laboratory findings suggested cytotoxic T-cell immune responses.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined